-
1
-
-
0034983045
-
Diagnostic criteria and classification of mastocytosis: A consensus proposal
-
Valent P, Horny HP, Escribano L, et al: Diagnostic criteria and classification of mastocytosis: A consensus proposal. Leuk Res 25:603-625, 2001
-
(2001)
Leuk Res
, vol.25
, pp. 603-625
-
-
Valent, P.1
Horny, H.P.2
Escribano, L.3
-
3
-
-
69349102308
-
Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients
-
Escribano L, Alvarez-Twose I, Sánchez-Muñoz L, et al: Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol 124:514-521, 2009
-
(2009)
J Allergy Clin Immunol
, vol.124
, pp. 514-521
-
-
Escribano, L.1
Alvarez-Twose, I.2
Sánchez-Muñoz, L.3
-
4
-
-
61549132662
-
Mastocytosis
-
Swerdlow SH, Campo E, Harris NL, et al eds :, Lyon, France, IARC
-
Horny HP, Metcalfe DD, Bennet JM, et al: Mastocytosis, in Swerdlow SH, Campo E, Harris NL, et al (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed 4). Lyon, France, IARC, 2008, pp 54-63
-
(2008)
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed 4)
, pp. 54-63
-
-
Horny, H.P.1
Metcalfe, D.D.2
Bennet, J.M.3
-
5
-
-
84855982233
-
Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: A case review
-
Ustun C, Savage NM, Gotlib J, et al: Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: A case review. Am J Hematol 87:191-193, 2012
-
(2012)
Am J Hematol
, vol.87
, pp. 191-193
-
-
Ustun, C.1
Savage, N.M.2
Gotlib, J.3
-
6
-
-
67651120132
-
Systemic mastocytosis in 342 consecutive adults: Survival studies and prognostic factors
-
Lim KH, Tefferi A, Lasho TL, et al: Systemic mastocytosis in 342 consecutive adults: Survival studies and prognostic factors. Blood 113:5727-5736, 2009
-
(2009)
Blood
, vol.113
, pp. 5727-5736
-
-
Lim, K.H.1
Tefferi, A.2
Lasho, T.L.3
-
7
-
-
70449706224
-
Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies
-
Pardanani A, Lim KH, Lasho TL, et al: Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies. Blood 114:3769-3772, 2009
-
(2009)
Blood
, vol.114
, pp. 3769-3772
-
-
Pardanani, A.1
Lim, K.H.2
Lasho, T.L.3
-
8
-
-
78650673033
-
How I treat patients with advanced systemic mastocytosis
-
Valent P, Sperr WR, Akin C: How I treat patients with advanced systemic mastocytosis. Blood 116:5812-5817, 2010
-
(2010)
Blood
, vol.116
, pp. 5812-5817
-
-
Valent, P.1
Sperr, W.R.2
Akin, C.3
-
10
-
-
0026570013
-
Response to interferon alfa-2b in a patient with systemic mastocytosis
-
Kluin-Nelemans HC, Jansen JH, Breukelman H, et al: Response to interferon alfa-2b in a patient with systemic mastocytosis. N Engl J Med 326:619-623, 1992
-
(1992)
N Engl J Med
, vol.326
, pp. 619-623
-
-
Kluin-Nelemans, H.C.1
Jansen, J.H.2
Breukelman, H.3
-
11
-
-
12144257058
-
Kit as a human oncogenic tyrosine kinase
-
Kitamura Y, Hirotab S: Kit as a human oncogenic tyrosine kinase. Cell Mol Life Sci 61:2924-2931, 2004
-
(2004)
Cell Mol Life Sci
, vol.61
, pp. 2924-2931
-
-
Kitamura, Y.1
Hirotab, S.2
-
12
-
-
21344465615
-
Clonality and molecular pathogenesis of mastocytosis
-
Akin C: Clonality and molecular pathogenesis of mastocytosis. Acta Haematol 114:61-69, 2005
-
(2005)
Acta Haematol
, vol.114
, pp. 61-69
-
-
Akin, C.1
-
13
-
-
0028849992
-
C-kit point mutation of extracellular domain in patients with myeloproliferative disorders
-
Nakata Y, Kimura A, Katoh O, et al: c-kit point mutation of extracellular domain in patients with myeloproliferative disorders. Br J Haematol 91:661-663, 1995
-
(1995)
Br J Haematol
, vol.91
, pp. 661-663
-
-
Nakata, Y.1
Kimura, A.2
Katoh, O.3
-
14
-
-
33749368009
-
KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: A prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients
-
Garcia-Montero AC, Jara-Acevedo M, Teodosio C, et al: KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: A prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 108:2366-2372, 2006
-
(2006)
Blood
, vol.108
, pp. 2366-2372
-
-
Garcia-Montero, A.C.1
Jara-Acevedo, M.2
Teodosio, C.3
-
15
-
-
0028856070
-
Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder
-
Nagata H, Worobec AS, Oh CK, et al: Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci U S A 92:10560-10564, 1995
-
(1995)
Proc Natl Acad Sci U S A
, vol.92
, pp. 10560-10564
-
-
Nagata, H.1
Worobec, A.S.2
Oh, C.K.3
-
16
-
-
0009013631
-
Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm
-
Longley BJ, Tyrrell L, Lu SZ, et al: Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm. Nat Genet 12:312-314, 1996
-
(1996)
Nat Genet
, vol.12
, pp. 312-314
-
-
Longley, B.J.1
Tyrrell, L.2
Lu, S.Z.3
-
17
-
-
13044305857
-
Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis
-
Longley BJ Jr, Metcalfe DD, Tharp M, et al: Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci U S A 96:1609-1614, 1999
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 1609-1614
-
-
Longley, B.J.1
Metcalfe, D.D.2
Tharp, M.3
-
18
-
-
80051475544
-
Tyrosine kinase inhibitors in the treatment of systemic mastocytosis
-
Ustun C, DeRemer DL, Akin C: Tyrosine kinase inhibitors in the treatment of systemic mastocytosis. Leuk Res 35:1143-1152, 2011
-
(2011)
Leuk Res
, vol.35
, pp. 1143-1152
-
-
Ustun, C.1
DeRemer, D.L.2
Akin, C.3
-
19
-
-
1842579440
-
A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib
-
Akin C, Fumo G, Yavuz AS, et al: A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood 103:3222-3225, 2004
-
(2004)
Blood
, vol.103
, pp. 3222-3225
-
-
Akin, C.1
Fumo, G.2
Yavuz, A.S.3
-
20
-
-
0041656424
-
Imatinib for systemic mast-cell disease
-
Pardanani A, Elliott M, Reeder T, et al: Imatinib for systemic mast-cell disease. Lancet 362:535-536, 2003
-
(2003)
Lancet
, vol.362
, pp. 535-536
-
-
Pardanani, A.1
Elliott, M.2
Reeder, T.3
-
21
-
-
54349097778
-
Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis
-
Aichberger KJ, Sperr WR, Gleixner KV, et al: Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis. Eur J Clin Invest 38:869-873, 2008
-
(2008)
Eur J Clin Invest
, vol.38
, pp. 869-873
-
-
Aichberger, K.J.1
Sperr, W.R.2
Gleixner, K.V.3
-
22
-
-
61449256026
-
Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V
-
Ustun C, Corless CL, Savage N, et al: Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V. Leuk Res 33:735-741, 2009
-
(2009)
Leuk Res
, vol.33
, pp. 735-741
-
-
Ustun, C.1
Corless, C.L.2
Savage, N.3
-
23
-
-
52449085884
-
Phase II study of dasatinib in Philadelphia chromosomenegative acute and chronic myeloid diseases, including systemic mastocytosis
-
Verstovsek S, Tefferi A, Cortes J, et al: Phase II study of dasatinib in Philadelphia chromosomenegative acute and chronic myeloid diseases, including systemic mastocytosis. Clin Cancer Res 14:3906-3915, 2008
-
(2008)
Clin Cancer Res
, vol.14
, pp. 3906-3915
-
-
Verstovsek, S.1
Tefferi, A.2
Cortes, J.3
-
24
-
-
27144506215
-
Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation
-
Gotlib J, Berubé C, Growney JD, et al: Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. Blood 106:2865-2870, 2005
-
(2005)
Blood
, vol.106
, pp. 2865-2870
-
-
Gotlib, J.1
Berubé, C.2
Growney, J.D.3
-
25
-
-
36349020293
-
Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT
-
Gleixner KV, Mayerhofer M, Sonneck K, et al: Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT. Haematologica 92:1451-1459, 2007
-
(2007)
Haematologica
, vol.92
, pp. 1451-1459
-
-
Gleixner, K.V.1
Mayerhofer, M.2
Sonneck, K.3
-
26
-
-
30444446680
-
PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: Comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects
-
Gleixner KV, Mayerhofer M, Aichberger KJ, et al: PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: Comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects. Blood 107:752-759, 2006
-
(2006)
Blood
, vol.107
, pp. 752-759
-
-
Gleixner, K.V.1
Mayerhofer, M.2
Aichberger, K.J.3
-
27
-
-
79952129510
-
Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: Myths, controversies, and unknowns
-
Gupta V, Tallman MS, Weisdorf DJ: Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: Myths, controversies, and unknowns. Blood 117:2307-2318, 2011
-
(2011)
Blood
, vol.117
, pp. 2307-2318
-
-
Gupta, V.1
Tallman, M.S.2
Weisdorf, D.J.3
-
28
-
-
26444578394
-
Myelomastocytic leukemia: Evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation
-
Sperr WR, Drach J, Hauswirth AW, et al: Myelomastocytic leukemia: Evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation. Clin Cancer Res 11:6787-6792, 2005
-
(2005)
Clin Cancer Res
, vol.11
, pp. 6787-6792
-
-
Sperr, W.R.1
Drach, J.2
Hauswirth, A.W.3
-
29
-
-
0028081256
-
Origin of human mast cells: Development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation
-
Fö dinger M, Fritsch G, Winkler K, et al: Origin of human mast cells: Development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. Blood 84:2954-2959, 1994
-
(1994)
Blood
, vol.84
, pp. 2954-2959
-
-
Dinger, M.F.1
Fritsch, G.2
Winkler, K.3
-
30
-
-
0031963620
-
Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: Review of forty cases
-
Przepiorka D, Giralt S, Khouri I, et al: Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: Review of forty cases. Am J Hematol 57:24-28, 1998
-
(1998)
Am J Hematol
, vol.57
, pp. 24-28
-
-
Przepiorka, D.1
Giralt, S.2
Khouri, I.3
-
31
-
-
0037405219
-
Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: Analysis of clinicopathologic features and activating c-kit mutations
-
Pullarkat VA, Bueso-Ramos C, Lai R, et al: Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: Analysis of clinicopathologic features and activating c-kit mutations. Am J Hematol 73:12-17, 2003
-
(2003)
Am J Hematol
, vol.73
, pp. 12-17
-
-
Pullarkat, V.A.1
Bueso-Ramos, C.2
Lai, R.3
-
32
-
-
0026094783
-
Persistence of systemic mastocytosis after allogeneic bone marrow transplantation in spite of complete remission of the associated myelodysplastic syndrome
-
Rønnov-Jessen D, Løvgreen Nielsen P, Horn T: Persistence of systemic mastocytosis after allogeneic bone marrow transplantation in spite of complete remission of the associated myelodysplastic syndrome. Bone Marrow Transplant 8:413-415, 1991
-
(1991)
Bone Marrow Transplant
, vol.8
, pp. 413-415
-
-
Rønnov-Jessen, D.1
Løvgreen Nielsen, P.2
Horn, T.3
-
33
-
-
33845193026
-
Neoplastic mast cells in systemic mastocytosis associated with t (8;21) acute myeloid leukemia are derived from the leukemic clone
-
Pullarkat V, Bedell V, Kim Y, et al: Neoplastic mast cells in systemic mastocytosis associated with t (8;21) acute myeloid leukemia are derived from the leukemic clone. Leuk Res 31:261-265, 2007
-
(2007)
Leuk Res
, vol.31
, pp. 261-265
-
-
Pullarkat, V.1
Bedell, V.2
Kim, Y.3
-
34
-
-
4644303507
-
Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantation
-
Spyridonidis A, Thomas AK, Bertz H, et al: Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantation. Bone Marrow Transplant 34:515-519, 2004
-
(2004)
Bone Marrow Transplant
, vol.34
, pp. 515-519
-
-
Spyridonidis, A.1
Thomas, A.K.2
Bertz, H.3
-
35
-
-
35448970526
-
The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia
-
Nagai S, Ichikawa M, Takahashi T, et al: The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia. Exp Hematol 35:1747-1752, 2007
-
(2007)
Exp Hematol
, vol.35
, pp. 1747-1752
-
-
Nagai, S.1
Ichikawa, M.2
Takahashi, T.3
-
36
-
-
0038493777
-
Rapid engraftment of mast cells of donor origin in a case of acute myeloid leukemia with mast cell leukemia after allogeneic stem cell transplantation
-
Chen TY, Chen JS, Huang WT, et al: Rapid engraftment of mast cells of donor origin in a case of acute myeloid leukemia with mast cell leukemia after allogeneic stem cell transplantation. Bone Marrow Transplant 32:111-114, 2003
-
(2003)
Bone Marrow Transplant
, vol.32
, pp. 111-114
-
-
Chen, T.Y.1
Chen, J.S.2
Huang, W.T.3
-
37
-
-
32844466631
-
A pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis
-
Nakamura R, Chakrabarti S, Akin C, et al: A pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis. Bone Marrow Transplant 37:353-358, 2006
-
(2006)
Bone Marrow Transplant
, vol.37
, pp. 353-358
-
-
Nakamura, R.1
Chakrabarti, S.2
Akin, C.3
-
38
-
-
84877669323
-
Delayed graft-versus-mast-cell effect on systemic mastocytosis with associated clonal haematological nonmast cell lineage disease after allogeneic transplantation
-
Gromke T, Elmaagacli AH, Ditschkowski M, et al: Delayed graft-versus-mast-cell effect on systemic mastocytosis with associated clonal haematological nonmast cell lineage disease after allogeneic transplantation. Bone Marrow Transplant 48:732-733, 2013
-
(2013)
Bone Marrow Transplant
, vol.48
, pp. 732-733
-
-
Gromke, T.1
Elmaagacli, A.H.2
Ditschkowski, M.3
-
40
-
-
84866413744
-
Death from mast cell leukemia: A young patient with longstanding cutaneous mastocytosis evolving into fatal mast cell leukemia
-
Chantorn R, Shwayder T: Death from mast cell leukemia: A young patient with longstanding cutaneous mastocytosis evolving into fatal mast cell leukemia. Pediatr Dermatol 29:605-609, 2012
-
(2012)
Pediatr Dermatol
, vol.29
, pp. 605-609
-
-
Chantorn, R.1
Shwayder, T.2
-
41
-
-
0345772088
-
Aggressive systemic mastocytosis and related mast cell disorders: Current treatment options and proposed response criteria
-
Valent P, Akin C, Sperr WR, et al: Aggressive systemic mastocytosis and related mast cell disorders: Current treatment options and proposed response criteria. Leuk Res 27:635-641, 2003
-
(2003)
Leuk Res
, vol.27
, pp. 635-641
-
-
Valent, P.1
Akin, C.2
Sperr, W.R.3
-
42
-
-
84878423607
-
International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis
-
Gotlib J, Pardanani A, Akin C, et al: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis. Blood 121:2393-2401, 2013
-
(2013)
Blood
, vol.121
, pp. 2393-2401
-
-
Gotlib, J.1
Pardanani, A.2
Akin, C.3
-
43
-
-
84872606296
-
Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remission
-
Oran B, Popat U, Rondon G, et al: Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remission. Biol Blood Marrow Transplant 19:214-220, 2013
-
(2013)
Biol Blood Marrow Transplant
, vol.19
, pp. 214-220
-
-
Oran, B.1
Popat, U.2
Rondon, G.3
-
44
-
-
58149196171
-
Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: Importance of pretransplant disease burden
-
Warlick ED, Cioc A, Defor T, et al: Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: Importance of pretransplant disease burden. Biol Blood Marrow Transplant 15:30-38, 2009
-
(2009)
Biol Blood Marrow Transplant
, vol.15
, pp. 30-38
-
-
Warlick, E.D.1
Cioc, A.2
Defor, T.3
-
45
-
-
77956404446
-
Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia
-
Gyurkocza B, Storb R, Storer BE, et al: Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia. J Clin Oncol 28:2859-2867, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 2859-2867
-
-
Gyurkocza, B.1
Storb, R.2
Storer, B.E.3
-
46
-
-
10744228781
-
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: Disease status by marrow blasts is the strongest prognostic factor
-
Sayer HG, Kröger M, Beyer J, et al: Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: Disease status by marrow blasts is the strongest prognostic factor. Bone Marrow Transplant 31:1089-1095, 2003
-
(2003)
Bone Marrow Transplant
, vol.31
, pp. 1089-1095
-
-
Sayer, H.G.1
Kröger, M.2
Beyer, J.3
-
47
-
-
77957278020
-
Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure
-
Duval M, Klein JP, He W, et al: Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol 28:3730-3738, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 3730-3738
-
-
Duval, M.1
Klein, J.P.2
He, W.3
-
48
-
-
84877684716
-
Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia
-
Buckley SA, Appelbaum FR, Walter RB: Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia. Bone Marrow Transplant 48:630-641, 2013
-
(2013)
Bone Marrow Transplant
, vol.48
, pp. 630-641
-
-
Buckley, S.A.1
Appelbaum, F.R.2
Walter, R.B.3
-
49
-
-
84887231975
-
Achieving stringent CR is essential before reducedintensity conditioning allogeneic hematopoietic cell transplantation in AML
-
Ustun C, Wiseman AC, Defor TE, et al: Achieving stringent CR is essential before reducedintensity conditioning allogeneic hematopoietic cell transplantation in AML. Bone Marrow Transplant 48:1415-1420, 2013
-
(2013)
Bone Marrow Transplant
, vol.48
, pp. 1415-1420
-
-
Ustun, C.1
Wiseman, A.C.2
Defor, T.E.3
-
50
-
-
84055218304
-
Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management
-
Estey EH: Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 87:89-99, 2012
-
(2012)
Am J Hematol
, vol.87
, pp. 89-99
-
-
Estey, E.H.1
-
51
-
-
0037114753
-
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B (CALGB 8461)
-
Byrd JC, Mrózek K, Dodge RK, et al: Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B (CALGB 8461). Blood 100:4325-4336, 2002
-
(2002)
Blood
, vol.100
, pp. 4325-4336
-
-
Byrd, J.C.1
Mrózek, K.2
Dodge, R.K.3
-
52
-
-
0034672269
-
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group Study
-
Slovak ML, Kopecky KJ, Cassileth PA, et al: Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 96:4075-4083, 2000
-
(2000)
Blood
, vol.96
, pp. 4075-4083
-
-
Slovak, M.L.1
Kopecky, K.J.2
Cassileth, P.A.3
-
53
-
-
85027957783
-
Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: Clinical significance and comparison of chromosomal abnormalities in SM and AHNMD components
-
Wang SA, Hutchinson L, Tang G, et al: Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: Clinical significance and comparison of chromosomal abnormalities in SM and AHNMD components. Am J Hematol 88:219-224, 2013
-
(2013)
Am J Hematol
, vol.88
, pp. 219-224
-
-
Wang, S.A.1
Hutchinson, L.2
Tang, G.3
-
54
-
-
84884948790
-
Hidden mastocytosis in acute myeloid leukemia with t (8;21) (q22;q22)
-
Johnson RC, Savage NM, Chiang T, et al: Hidden mastocytosis in acute myeloid leukemia with t (8;21) (q22;q22). Am J Clin Pathol 140:525-535, 2013
-
(2013)
Am J Clin Pathol
, vol.140
, pp. 525-535
-
-
Johnson, R.C.1
Savage, N.M.2
Chiang, T.3
-
55
-
-
33748467435
-
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv (16) and t (8; 21): A Cancer and Leukemia Group B Study
-
Paschka P, Marcucci G, Ruppert AS, et al: Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv (16) and t (8; 21): A Cancer and Leukemia Group B Study. J Clin Oncol 24:3904-3911, 2006
-
(2006)
J Clin Oncol
, vol.24
, pp. 3904-3911
-
-
Paschka, P.1
Marcucci, G.2
Ruppert, A.S.3
-
56
-
-
33744487375
-
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)
-
Boissel N, Leroy H, Brethon B, et al: Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML). Leukemia 20:965-970, 2006
-
(2006)
Leukemia
, vol.20
, pp. 965-970
-
-
Boissel, N.1
Leroy, H.2
Brethon, B.3
-
57
-
-
80052097088
-
Prognostic impact of c-KIT mutations in core binding factor acute myeloid leukemia
-
Park SH, Chi HS, Min SK, et al: Prognostic impact of c-KIT mutations in core binding factor acute myeloid leukemia. Leuk Res 35:1376-1383, 2011
-
(2011)
Leuk Res
, vol.35
, pp. 1376-1383
-
-
Park, S.H.1
Chi, H.S.2
Min, S.K.3
-
58
-
-
33646432204
-
Prognostic impact of c-KIT mutations in core binding factor leukemias: An Italian retrospective study
-
Cairoli R, Beghini A, Grillo G, et al: Prognostic impact of c-KIT mutations in core binding factor leukemias: An Italian retrospective study. Blood 107:3463-3468, 2006
-
(2006)
Blood
, vol.107
, pp. 3463-3468
-
-
Cairoli, R.1
Beghini, A.2
Grillo, G.3
-
59
-
-
19944431253
-
AML1-ETO and C-KIT mutation/overexpression in t (8;21) leukemia: Implication in stepwise leukemogenesis and response to Gleevec
-
Wang YY, Zhou GB, Yin T, et al: AML1-ETO and C-KIT mutation/overexpression in t (8;21) leukemia: Implication in stepwise leukemogenesis and response to Gleevec. Proc Natl Acad Sci U S A 102:1104-1109, 2005
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 1104-1109
-
-
Wang, Y.Y.1
Zhou, G.B.2
Yin, T.3
-
60
-
-
77955275396
-
High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V
-
Fritsche-Polanz R, Fritz M, Huber A, et al: High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V. Mol Oncol 4:335-346, 2010
-
(2010)
Mol Oncol
, vol.4
, pp. 335-346
-
-
Fritsche-Polanz, R.1
Fritz, M.2
Huber, A.3
-
62
-
-
31444444950
-
Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: The role of dose intensity
-
Shimoni A, Hardan I, Shem-Tov N, et al: Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: The role of dose intensity. Leukemia 20:322-328, 2006
-
(2006)
Leukemia
, vol.20
, pp. 322-328
-
-
Shimoni, A.1
Hardan, I.2
Shem-Tov, N.3
-
63
-
-
76749091954
-
Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia
-
Ringdén O, Labopin M, Ehninger G, et al: Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia. J Clin Oncol 27:4570-4577, 2009
-
(2009)
J Clin Oncol
, vol.27
, pp. 4570-4577
-
-
Ringdén, O.1
Labopin, M.2
Ehninger, G.3
-
64
-
-
77955886057
-
The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission
-
Marks DI, Wang T, Pérez WS, et al: The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission. Blood 116:366-374, 2010
-
(2010)
Blood
, vol.116
, pp. 366-374
-
-
Marks, D.I.1
Wang, T.2
Pérez, W.S.3
-
65
-
-
77951649470
-
Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome
-
McClune BL, Weisdorf DJ, Pedersen TL, et al: Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. J Clin Oncol 28:1878-1887, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 1878-1887
-
-
McClune, B.L.1
Weisdorf, D.J.2
Pedersen, T.L.3
-
66
-
-
25144445759
-
Quantitation of minimal residual disease in acute myeloid leukemia by tryptase monitoring identifies a group of patients with a high risk of relapse
-
Sperr WR, Mitterbauer M, Mitterbauer G, et al: Quantitation of minimal residual disease in acute myeloid leukemia by tryptase monitoring identifies a group of patients with a high risk of relapse. Clin Cancer Res 11:6536-6543, 2005
-
(2005)
Clin Cancer Res
, vol.11
, pp. 6536-6543
-
-
Sperr, W.R.1
Mitterbauer, M.2
Mitterbauer, G.3
-
67
-
-
70349256069
-
Elevated tryptase levels selectively cluster in myeloid neoplasms: A novel diagnostic approach and screen marker in clinical haematology
-
Sperr WR, El-Samahi A, Kundi M, et al: Elevated tryptase levels selectively cluster in myeloid neoplasms: A novel diagnostic approach and screen marker in clinical haematology. Eur J Clin Invest 39:914-923, 2009
-
(2009)
Eur J Clin Invest
, vol.39
, pp. 914-923
-
-
Sperr, W.R.1
El-Samahi, A.2
Kundi, M.3
-
68
-
-
0035496941
-
Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia
-
Sperr WR, Jordan JH, Baghestanian M, et al: Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood 98:2200-2209, 2001
-
(2001)
Blood
, vol.98
, pp. 2200-2209
-
-
Sperr, W.R.1
Jordan, J.H.2
Baghestanian, M.3
-
69
-
-
0031760986
-
Expression of functional major histocompatibility complex class II molecules on HMC-1 human mast cells
-
Dimitriadou V, Mécheri S, Koutsilieris M, et al: Expression of functional major histocompatibility complex class II molecules on HMC-1 human mast cells. J Leukoc Biol 64:791-799, 1998
-
(1998)
J Leukoc Biol
, vol.64
, pp. 791-799
-
-
Dimitriadou, V.1
Mécheri, S.2
Koutsilieris, M.3
-
70
-
-
0024439821
-
Intrathyroidal mast cells express major histocompatibility complex class-II antigens
-
Banovac K, Ghandur-Mnaymneh L, Leone J, et al: Intrathyroidal mast cells express major histocompatibility complex class-II antigens. Int Arch Allergy Appl Immunol 90:43-46, 1989
-
(1989)
Int Arch Allergy Appl Immunol
, vol.90
, pp. 43-46
-
-
Banovac, K.1
Ghandur-Mnaymneh, L.2
Leone, J.3
-
71
-
-
0030043421
-
Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells
-
Malaviya R, Twesten NJ, Ross EA, et al: Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol 156:1490-1496, 1996
-
(1996)
J Immunol
, vol.156
, pp. 1490-1496
-
-
Malaviya, R.1
Twesten, N.J.2
Ross, E.A.3
-
72
-
-
65249097891
-
Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation
-
Kambayashi T, Allenspach EJ, Chang JT, et al: Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation. J Immunol 182:4686-4695, 2009
-
(2009)
J Immunol
, vol.182
, pp. 4686-4695
-
-
Kambayashi, T.1
Allenspach, E.J.2
Chang, J.T.3
-
73
-
-
84875524917
-
Dissecting graft-versusleukemia from graft-versus-host-disease using novel strategies
-
Warren EH, Deeg HJ: Dissecting graft-versusleukemia from graft-versus-host-disease using novel strategies. Tissue Antigens 81:183-193, 2013
-
(2013)
Tissue Antigens
, vol.81
, pp. 183-193
-
-
Warren, E.H.1
Deeg, H.J.2
-
75
-
-
33748320914
-
Mast cells are essential intermediaries in regulatory T-cell tolerance
-
Lu LF, Lind EF, Gondek DC, et al: Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442:997-1002, 2006
-
(2006)
Nature
, vol.442
, pp. 997-1002
-
-
Lu, L.F.1
Lind, E.F.2
Gondek, D.C.3
-
77
-
-
0037229996
-
Recent advances in allogeneic hematopoietic stemcell transplantation
-
Devine SM, Adkins DR, Khoury H, et al: Recent advances in allogeneic hematopoietic stemcell transplantation. J Lab Clin Med 141:7-32, 2003.
-
(2003)
J Lab Clin Med
, vol.141
, pp. 7-32
-
-
Devine, S.M.1
Adkins, D.R.2
Khoury, H.3
|